Bryan T Mayer (Bryan Mayer, B T Mayer)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Men Who Have Sex With Men

Monoclonal Antibody

Top Venues

Nature communications

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Emily Locke, Yevel Flores-Garcia, Bryan T Mayer, Randall S MacGill, Bhavesh Borate, Berenice Salgado-Jimenez, Monica W Gerber, Shamika Mathis-Torres, Sarah Shapiro, C Richter King, Fidel Zavala
Establishing RTS,S/AS01 as a benchmark for comparison to next-generation malaria vaccines in a mouse model. NPJ vaccines 9 (1) (2024)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 15 (1) (2024)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 15 (1) (2024)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 15 (1) (2024)
Emily Locke, Yevel Flores-Garcia, Bryan T Mayer, Randall S MacGill, Bhavesh Borate, Berenice Salgado-Jimenez, Monica W Gerber, Shamika Mathis-Torres, Sarah Shapiro, C Richter King, Fidel Zavala
Establishing RTS,S/AS01 as a benchmark for comparison to next-generation malaria vaccines in a mouse model. NPJ vaccines 9 (1) (2024)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 15 (1) (2024)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Bryan T Mayer, Allan C deCamp, Yunda Huang, Joshua T Schiffer, Raphaël Gottardo, Peter B Gilbert, Daniel B Reeves
Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention. PLoS computational biology 18 (4) (2022)
Boris Julg, Kathryn E Stephenson, Kshitij Wagh, Sabrina C Tan, Rebecca Zash, Stephen R Walsh, Jessica Ansel, Diane Kanjilal, Joseph Nkolola, Victoria E K Walker-Sperling, Jasper Ophel, Katherine Yanosick, Erica N Borducchi, Lori F Maxfield, Peter Abbink, Lauren Peter, Nicole L Yates, Martina S Wesley, Tom Hassell, Huub C Gelderblom, Allen deCamp, Bryan T Mayer, Alicia Sato, Monica W Gerber, Elena E Giorgi, Lucio Gama, Richard A Koup, John R Mascola, Ana Monczor, Sofia Lupo, Charlotte-Paige Rolle, Roberto Arduino, Edwin DeJesus, Georgia D Tomaras, Michael S Seaman, Bette T Korber, Dan H Barouch
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial. Nature medicine 28 (6) (2022)
Ashish Goyal, Matthew R Gardner, Bryan T Mayer, Keith R Jerome, Michael Farzan, Joshua T Schiffer, Erwing Fabian Cardozo Ojeda
Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission. Science advances 8 (2) (2022)
Peter B Gilbert, Yunda Huang, Allan C deCamp, Shelly T Karuna, Yuanyuan Zhang, Craig A Magaret, Elena E Giorgi, Bette T Korber, Paul T Edlefsen, Raabya Rossenkhan, Michal Juraska, Erika Rudnicki, Nidhi Kochar, Ying Huang, Lindsay N Carpp, Dan H Barouch, Nonhlanhla N Mkhize, Tandile Hermanus, Prudence Kgagudi, Valerie Bekker, Haajira Kaldine, Rutendo E Mapengo, Amanda Eaton, Elize Domin, Carley West, Wenhong Feng, Haili Tang, Kelly E Seaton, Jack Heptinstall, Caroline Brackett, Kelvin Chiong, Georgia D Tomaras, Philip Andrew, Bryan T Mayer, Daniel B Reeves, Magdalena E Sobieszczyk, Sharana Mahomed, Jorge Sanchez, Cynthia Gay, Joseph Makhema, Carolyn Williamson, James I Mullins, John Hural, Myron S Cohen, Lawrence Corey, David C Montefiori, Lynn Morris
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition. Nature medicine 28 (9) (2022)
Kathryn E Stephenson, Boris Julg, C Sabrina Tan, Rebecca Zash, Stephen R Walsh, Charlotte-Paige Rolle, Ana N Monczor, Sofia Lupo, Huub C Gelderblom, Jessica L Ansel, Diane G Kanjilal, Lori F Maxfield, Joseph Nkolola, Erica N Borducchi, Peter Abbink, Jinyan Liu, Lauren Peter, Abishek Chandrashekar, Ramya Nityanandam, Zijin Lin, Alessandra Setaro, Joseph Sapiente, Zhilin Chen, Lisa Sunner, Tyler Cassidy, Chelsey Bennett, Alicia Sato, Bryan T Mayer, Alan S Perelson, Allan deCamp, Frances H Priddy, Kshitij Wagh, Elena E Giorgi, Nicole L Yates, Roberto C Arduino, Edwin DeJesus, Georgia D Tomaras, Michael S Seaman, Bette Korber, Dan H Barouch
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial. Nature medicine 27 (10) (2021)
Yves Lévy, Christine Lacabaratz, Kim Ellefsen-Lavoie, Wolfgang Stöhr, Jean-Daniel Lelièvre, Pierre-Alexandre Bart, Odile Launay, Jonathan Weber, Bernd Salzberger, Aurélie Wiedemann, Mathieu Surenaud, David M Koelle, Hans Wolf, Ralf Wagner, Véronique Rieux, David C Montefiori, Nicole L Yates, Georgia D Tomaras, Raphael Gottardo, Bryan T Mayer, Song Ding, Rodolphe Thiébaut, Sheena McCormack, Geneviève Chêne, Giuseppe Pantaleo
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial. PLoS pathogens 16 (6) (2020)
M Giel-Moloney, M Esteban, B H Oakes, M Vaine, B Asbach, R Wagner, G J Mize, A G Spies, J McElrath, M Perreau, T Roger, A Ives, T Calandra, D Weiss, B Perdiguero, K V Kibler, B Jacobs, S Ding, G D Tomaras, D C Montefiori, G Ferrari, N L Yates, M Roederer, S F Kao, K E Foulds, Bryan T Mayer, C Bennett, Raphaël Gottardo, M Parrington, J Tartaglia, S Phogat, G Pantaleo, H Kleanthous, K V Pugachev
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector. Scientific reports 9 (1) (2019)